Insights

Expanding Cannabis Portfolio Purisys produces over 50 cannabinoids and related standards, supporting pharma, biotech, and research markets worldwide. This positions the company as a key partner for organizations developing cannabinoid-based therapies or research tools, offering opportunities for collaborations or product sourcing in the rapidly growing cannabis science sector.

Specialized API Capabilities With expertise in complex APIs including controlled substances, HPAPIs, and environmentally sensitive molecules, Purisys is well-suited to serve clients requiring custom, difficult-to-manufacture APIs. This creates potential sales avenues in niche drug development and regulatory-compliant manufacturing for innovative pharmaceutical companies.

Recent Strategic Partnerships Recent collaborations with companies like Ensysce Biosciences and Neuropathix highlight Purisys’s capability to support opioid use disorder treatments and process optimizations, indicating opportunities to expand into specialized pain management and neurotherapeutics markets with targeted API solutions.

Regulatory-Ready Product Line Purisys maintains multiple DMFs for key cannabinoids and psychedelics, demonstrating readiness for regulated markets. This compliance facilitates quick entry for clients seeking to advance clinical trials and commercial approvals, making Purisys an attractive partner for companies aiming to accelerate product launch pipelines.

Global Reference Standards Stocking over 250 reference standards and shipping to more than 30 countries, Purisys offers reliable analytical support and quality assurance services. These capabilities present sales opportunities in research, quality control, and validation segments for organizations requiring high-quality standards globally.

Similar companies to Purisys - now part of the Siegfried Group

Purisys - now part of the Siegfried Group Tech Stack

Purisys - now part of the Siegfried Group uses 8 technology products and services including WordPress, Open Graph, Shopify, and more. Explore Purisys - now part of the Siegfried Group's tech stack below.

  • WordPress
    Content Management System
  • Open Graph
    Content Management System
  • Shopify
    E-commerce
  • Google Fonts API
    Font Scripts
  • Element UI
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Cloudflare Bot Management
    Security
  • Endurance Page Cache
    Web Platform Extensions

Purisys - now part of the Siegfried Group's Email Address Formats

Purisys - now part of the Siegfried Group uses at least 2 format(s):
Purisys - now part of the Siegfried Group Email FormatsExamplePercentage
FLast@purisys.comJDoe@purisys.com
100%

Frequently Asked Questions

Where is Purisys - now part of the Siegfried Group's headquarters located?

Minus sign iconPlus sign icon
Purisys - now part of the Siegfried Group's main headquarters is located at 1550 Olympic Drive Athens, Georgia 30601 United States. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Purisys - now part of the Siegfried Group's official website and social media links?

Minus sign iconPlus sign icon
Purisys - now part of the Siegfried Group's official website is content.siegfried.ch and has social profiles on LinkedIn.

What is Purisys - now part of the Siegfried Group's NAICS code?

Minus sign iconPlus sign icon
Purisys - now part of the Siegfried Group's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Purisys - now part of the Siegfried Group have currently?

Minus sign iconPlus sign icon
As of June 2026, Purisys - now part of the Siegfried Group has approximately 16 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Senior Director, Business Development: E. S.Director, Sales & Business Development: S. M.Director, Technical Business Development: A. B.. Explore Purisys - now part of the Siegfried Group's employee directory with LeadIQ.

What industry does Purisys - now part of the Siegfried Group belong to?

Minus sign iconPlus sign icon
Purisys - now part of the Siegfried Group operates in the Pharmaceutical Manufacturing industry.

What technology does Purisys - now part of the Siegfried Group use?

Minus sign iconPlus sign icon
Purisys - now part of the Siegfried Group's tech stack includes WordPressOpen GraphShopifyGoogle Fonts APIElement UIjQuery MigrateCloudflare Bot ManagementEndurance Page Cache.

What is Purisys - now part of the Siegfried Group's email format?

Minus sign iconPlus sign icon
Purisys - now part of the Siegfried Group's email format typically follows the pattern of FLast@purisys.com. Find more Purisys - now part of the Siegfried Group email formats with LeadIQ.

When was Purisys - now part of the Siegfried Group founded?

Minus sign iconPlus sign icon
Purisys - now part of the Siegfried Group was founded in 2019.

Purisys - now part of the Siegfried Group

Pharmaceutical ManufacturingGeorgia, United States11-50 Employees

Purisys is a global leader in custom synthesis of active pharmaceutical ingredients. We support pharma & biotech companies with APIs, reference standards, controlled substances, cannabinoids, psychedelics, and cGMP clinical & niche commercial CDMO services. Formed as a spin-off from Noramco in 2019, Purisys began manufacturing in 1979 as part of Johnson & Johnson.

WORLD LEADER IN PHARMACEUTICAL CANNABINOIDS, PSYCHEDELICS & REFERENCE STANDARDS 
Purisys produces 50+ major and minor cannabinoids, as well as degradants, metabolites & analytical standards to support our customers in this growing field. In addition, we have DEA licenses for several Psychedelic basic classes and have produced GMP psilocybin and Psilocin supporting customers’ R&D programs. We have multiple DMFs, including Dronabinol (#20682), CBD (#33223), Nabilone (#35408), and have produced other cannabinoids used worldwide in IND/IMPD/NDA/ANDA filings. 

CUSTOM API and DRUG DEVELOPMENT & MANUFACTURING (CDMO) SERVICES FOR PHARMA & BIOTECH
For clients seeking preclinical-to-commercial APIs, we provide comprehensive development, analytical and manufacturing services - including full-service clinical-to-commercial small volume & orphan drug commercial API synthesis in our FDA-inspected GMP manufacturing suites. Our custom synthesis projects include difficult-to-manufacture APIs (controlled substances, injectable-grade APIs, HPAPIs and environmentally sensitive APIs).

IN-STOCK REFERENCE STANDARDS AND CUSTOM SYNTHESIS SERVICES
Purisys stocks 250+ reference standards with structural elucidation and comprehensive analytical data. We ship reference standards to 30+ countries on 6 continents.

CAPABILITIES:
•	Cannabinoid and psychedelic APIs suitable for registered pharma research to treat, cure, or prevent disease
•	In-stock standards; custom synthesis & qualification
•	Excipient compatibility & formulation & solid state
•	cGMP manufacturing
•	HPAPI & labile molecule development 
•	Method development

Section iconCompany Overview

Headquarters
1550 Olympic Drive Athens, Georgia 30601 United States
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2019
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Purisys - now part of the Siegfried Group's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Purisys - now part of the Siegfried Group's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.